What Superstring Capital Management LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1931118 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 102.5K |
| +90.1% |
| $18.9M |
| 9.5% |
TRVITrevi Therapeutics, Inc. | 984.9K | +87.9% | $14.1M | 7.1% |
GMABGenmab A/S | 365.7K | −15.1% | $13M | 6.5% |
CLYMClimb Bio, Inc. | 918.2K | +76.2% | $10.5M | 5.3% |
ZLABZai Lab Ltd | 362.7K | +132.8% | $9.6M | 4.8% |
ANLAdlai Nortye Group Ltd. | 588.4K | +6.5% | $9.4M | 4.7% |
RVMDRevolution Medicines, Inc. | 41.8K | −18.2% | $8.6M | 4.3% |
CLDXCelldex Therapeutics, Inc. | 242.5K | −15.7% | $7.9M | 3.9% |
IMVTImmunovant, Inc. | 222.1K | +6.6% | $7.5M | 3.8% |
URGNUroGen Pharma Ltd. | 184.4K | −3.6% | $7.5M | 3.8% |
UTHRUnited Therapeutics Corp | 13.3K | +85.7% | $7.2M | 3.6% |
LEGNLegend Biotech Corp | 357.4K | New | $7.1M | 3.6% |
DFTXDefinium Therapeutics, Inc. | 176.6K | −6.2% | $6.7M | 3.4% |
ROIVRoivant Sciences Ltd. | 178.8K | +598.0% | $6.5M | 3.3% |
VIRVir Biotechnology, Inc. | 578.7K | −32.2% | $6.5M | 3.2% |
IONSIonis Pharmaceuticals Inc | 132.3K | New | $5.9M | 3% |
SVRASavara Inc | 1M | +4.1% | $5.3M | 2.6% |
SGMTSagimet Biosciences Inc. | 423K | New | $4.2M | 2.1% |
ABVXAbivax S.A. | 30K | New | $3M | 1.5% |
DNAGinkgo Bioworks Holdings, Inc. | 222.6K | New | $2.9M | 1.4% |
SYRESpyre Therapeutics, Inc. | 30K | New | $2.7M | 1.3% |
DRUGBright Minds Biosciences Inc. | 48K | +57.8% | $2.4M | 1.2% |
KNSAKiniksa Pharmaceuticals International, plc | 31.7K | +67.9% | $2.4M | 1.2% |
TSHATaysha Gene Therapies, Inc. | 413.4K | New | $2M | 1% |
LTGOLatigo Biotherapeutics, Inc. | 88.2K | New | $1.5M | 0.7% |
ORKAOruka Therapeutics, Inc. | 15.4K | New | $1.3M | 0.6% |
MPLTMapLight Therapeutics, Inc. | 118.3K | −5.7% | $1.2M | 0.6% |
MDGLMadrigal Pharmaceuticals, Inc. | 2.1K | New | $1.1M | 0.5% |
CABACabaletta Bio, Inc. | 517.4K | −59.5% | $993.4K | 0.5% |
XENEXenon Pharmaceuticals Inc. | 26.5K | New | $985.4K | 0.5% |
TNXPTonix Pharmaceuticals Holding Corp. | 74.7K | +17.3% | $727.5K | 0.4% |
BOLDBoundless Bio, Inc. | 206.2K | +272.6% | $517.7K | 0.3% |
GRALGrail, Inc. | 3.2K | New | $453.7K | 0.2% |
BMEABiomea Fusion, Inc. | 225.9K | −9.7% | $44.6K | 0.1% |